Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 USD | +4.10% | +7.52% | -6.54% |
05-13 | Wall Street Set to Open Higher Monday as Investors Look Toward Key Inflation Figures | MT |
05-13 | MiNK Therapeutics, Inc. announced that it expects to receive $5.8 million in funding | CI |
Business Summary
Number of employees: 31
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Buell
CEO | Chief Executive Officer | 50 | 31/01/21 |
Heather Boussios
CMP | Compliance Officer | - | - |
Marc van Dijk
CTO | Chief Tech/Sci/R&D Officer | 61 | 29/02/20 |
Zack Armen
IRC | Investor Relations Contact | - | - |
Treasurer | 58 | 30/06/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
CHM | Chairman | 71 | 30/06/17 |
Director/Board Member | 66 | 30/06/17 | |
Barbara Ryan
BRD | Director/Board Member | 64 | 31/08/21 |
Brian Corvese
BRD | Director/Board Member | 67 | 30/06/17 |
Peter Behner
BRD | Director/Board Member | 61 | 31/03/21 |
Jennifer Buell
CEO | Chief Executive Officer | 50 | 31/01/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 34,703,984 | 9,949,724 ( 28.67 %) | 0 | 28.67 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.54% | 34M | |
+29.65% | 48.16B | |
-1.01% | 41.73B | |
+43.06% | 41.03B | |
-5.31% | 28.77B | |
+10.22% | 25.59B | |
-21.21% | 18.96B | |
+6.70% | 12.92B | |
+26.92% | 12.03B | |
-3.10% | 11.77B |
- Stock Market
- Equities
- INKT Stock
- Company MiNK Therapeutics, Inc.